The Leadership Team at HiFiBiO Therapeutics is responsible for guiding the strategic vision and direction of the company. Comprised of the founders and key scientific leaders, this team drives the integration of innovative research and advanced biotherapeutics development, while fostering collaborations with industry and academic partners to enhance the company’s capabilities in mobilizing the human immune system to tackle cancer and autoimmune diseases. Their collective expertise ensures that HiFiBiO remains at the forefront of therapeutic advancements and patient care.
Andrew Griffiths
Scientific Founder
Bradley Bernstein
Scientific Founder
Dave Weitz
Scientific Founder
Francisco Adrian
Chief Scientific Officer
Jinping Gan
VP, Global Head of Research
Jérôme Bibette
Scientific Founder
Liang Schweizer
Founder, Chairperson & CEO
Robert Nicol
Scientific Founder
Sami Ellouze
Managing Director, France
View all